Titre : | Missing Data on the Estimation of the Prevalence of Accumulated Human Immunodeficiency Virus Drug Resistance in Patients Treated With Antiretroviral Drugs in North America. (2011) |
Auteurs : | Alison-G ABRAHAM ; Constance BENSON ; Ron BOSCH ; Ann COLLIER ; Steven DEEKS ; Joseph ERON ; Stephen-J GANGE ; Kelly GEBO ; Mjohn GILL ; James GOEDERT ; Richard HARRIGAN ; Robert HOGG ; Michael HORBERG ; Lisa JACOBSON ; . JINBING ZHANG ; Amy JUSTICE ; Greg KIRK ; Mari KITAHATA ; Marina Klein ; Bryan LAU ; Jeff Martin ; Rosemary MCKAIG ; Richard-D MOORE ; Sonia NAPRAVNIK ; Anita RACHLIS ; Benigno Rodriguez ; Sean ROURKE ; Michael SILVERBERG ; Timothy STERLING ; Jennifer THORNE ; James WILLIG ; North American Aids Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate Aids. INC |
Type de document : | Article |
Dans : | American journal of epidemiology (vol. 174, n° 6, 2011) |
Pagination : | 727-735 |
Langues: | Anglais |
Mots-clés : | Sida ; Estimation ; Prévalence ; VIH ; Homme ; Malade ; Thérapeutique ; Médicament antirétroviral ; Traitement antirétroviral ; Médicament antiviral ; Médicament ; Thérapeutique médicamenteuse ; Chimiothérapie ; Epidémiologie ; Virose ; Infection ; Rétrovirus ; Virus ; Amérique ; Immunopathologie ; Amérique du Nord |
Résumé : | [BDSP. Notice produite par INIST-CNRS 9R0xEDI8. Diffusion soumise à autorisation]. Determination of the prevalence of accumulated antiretroviral drug resistance among persons infected with human immunodeficiency virus (HIV) is complicated by the lack of routine measurement in clinical care. By using data from 8 clinic-based cohorts from the North American AIDS Cohort Collaboration on Research and Design, drug-resistance mutations from those with genotype tests were determined and scored using the Genotypic Resistance Interpretation Algorithm developed at Stanford University. For each year from 2000 through 2005, the prevalence was calculated using data from the tested subset, assumptions that incorporated clinical knowledge, and multiple imputation methods to yield a complete data set. A total of 9,289 patients contributed data to the analysis ; 3,959 had at least 1 viral load above 1,000 copies/mL, of whom 2,962 (75%) had undergone at least 1 genotype test. Using these methods, the authors estimated that the prevalence of accumulated resistance to 2 or more antiretroviral drug classes had increased from 14% in 2000 to 17% in 2005 (P |